Company / Interest Expense
Unicycive Therapeutics, Inc. Interest Expense History
FY2022-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$6.0K
FY2023
5-year range
$6.0K / $628.0K
FY2022-FY2023
Trend
-99.0%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$6,000 in FY2023.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2023, interest expense decreased 99.0% year-over-year.
Company context
Key Data Points
- Altman Z-Score -1.91 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | $6.0K | -99.0% |
| FY2022 | $628.0K | - |
As of FY2023 · SEC 10-K · Updated Jun 28, 2026